The US Food and Drug Administration has authorized an AI tool that estimates a woman's five-year breast cancer risk from a routine screening mammogram.

Is it true that the US Food and Drug Administration has authorized an AI tool that estimates a woman's five-year breast cancer risk from a routine screening mammogram?

Unclear. Several peer-reviewed items show mammography-based AI models that estimate a woman's five-year breast cancer risk, but none of the retrieved sources states that the FDA has authorized such a tool.

Verdict: PARTIAL LEAN · 3 sources for, 0 against · Last checked 2 Oct 2026

The private library was unavailable for some searches in this check. Missing library results are not evidence against the claim.

Jiang, S., Bennett, D. L., & Colditz, G. A. (2025). Data from Deriving a Mammogram-Based Risk Score from Screening Digital Breast Tomosynthesis for 5-Year Breast Cancer Risk Prediction. doi.org. https://doi.org/10.1158/1940-6207.c.7851704

Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine - PMC Lock. (n.d.). pmc.ncbi.nlm.nih.gov. https://doi.org/10.4048/jbc.2023.26.e45

M, K., CG, S., A, W., I, B., D, H., A, N., FF, W., R, C., F, C., S, P., D, K., AM, M., J, O., S, W., K, K., & CM, V. (2026). Performance of clinical breast cancer risk prediction models vs a mammography-based artificial intelligence risk model.. doi.org. https://doi.org/10.1093/jnci/djag083